works on

From the 1 of 16 linked papers with an AI index.

collaborators

16 papers

cs.AI2026

A decodability criterion predicts when hidden-state selection beats majority voting in large language models

Zhixiang wang, Ziliang Hong, Ulas Bagci

Combining the answers a large language model (LLM) samples for a question into one decision is a test-time information fusion problem, usually solved by majority voting. Voting is…

cs.CV2026

Gaussian Meta-Space Augmentation for Stacking Ensembles in Multimodal IPMN Risk Stratification

Max A. Nelson, Eminenur Sen Tasci, Zhixiang Wang +12

Pancreatic cancer is among the most lethal malignancies; risk stratification of intraductal papillary mucinous neoplasms (IPMNs) offers a crucial opportunity for early intervention…

eess.IV2026

BreastMammo and DenseMammo: Benchmarks for Mammography Domain Generalization

Hongyi Pan, Gorkem Durak, Halil Ertugrul Aktas +18

Breast density classification is a critical component of breast cancer risk assessment, yet AI models often struggle to generalize across clinical sites due to vendor-specific acqu…

cs.CV2026

Beyond Medical Diagnostics: How Medical Multimodal Large Language Models Think in Space

Quoc-Huy Trinh, Xi Ding, Yang Liu +7

The paper introduces SpatialMed, a benchmark and an automated pipeline that generates 3D spatial visual question‑answer pairs for medical imaging, and shows that current multimodal…

cs.CV2026

CORA: Generalizable coronary artery disease assessment and risk stratification from coronary CT angiography using pathology-centric representation learning

Jinkui Hao, Gorkem Durak, Halil Ertugrul Aktas +4

Coronary artery disease, a leading cause of cardiovascular mortality worldwide, can be assessed non-invasively by coronary computed tomography angiography (CCTA). Although deep lea…

eess.IV2026

LUMINA: A Multi-Vendor Mammography Benchmark with Energy Harmonization Protocol

Hongyi Pan, Gorkem Durak, Halil Ertugrul Aktas +9

Publicly available full-field digital mammography (FFDM) datasets remain limited in size, clinical annotations, and vendor diversity, hindering the development of robust models. We…